KYLE BRUSCHER: Open Payments
NPI 1346899846 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 19 payments from 12 companies in 2025. Trend: 2023 $195 · 2024 $308 · 2025 $736
Food & beverage: $736
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $142 |
| Boston Scientific Corporation | 3 | $135 |
| GENZYME CORPORATION | 1 | $125 |
| Actelion Pharmaceuticals US, Inc. | 1 | $106 |
| Philips North America LLC | 2 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| Amgen Inc. | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $23 |
| Novo Nordisk Inc | 1 | $21 |
Products named: CARDIOMEMS, WATCHMAN FLX, FABRAZYME, UPTRAVI, Ambulatory Monitoring & Diagnostics Undivided, EVKEEZA, REPATHA, LEQVIO.
Industry payments across SD — which companies pay providers there.
